Nom du produit:4-[4-(5-bromo-2-chlorobenzoyl)piperazin-1-yl]-6-(1H-1,2,4-triazol-1-yl)pyrimidine

IUPAC Name:4-[4-(5-bromo-2-chlorobenzoyl)piperazin-1-yl]-6-(1H-1,2,4-triazol-1-yl)pyrimidine

CAS:1798515-42-0
Formule moléculaire:C17H15BrClN7O
Pureté:95%+
Numéro de catalogue:CM879559
Poids moléculaire:448.71

Unité d'emballage Stock disponible Prix($) Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:1798515-42-0
Formule moléculaire:C17H15BrClN7O
Point de fusion:-
Code SMILES:ClC1=C(C=C(Br)C=C1)C(=O)N1CCN(CC1)C1=CC(=NC=N1)N1C=NC=N1
Densité:
Numéro de catalogue:CM879559
Poids moléculaire:448.71
Point d'ébullition:
N° Mdl:
Stockage:

Category Infos

Piperazines
Piperazine is an organic compound consisting of a six-membered ring containing two nitrogen atoms in opposite positions in the ring. The chemical formula of piperazine is C4H10N2, and it is an important pharmaceutical intermediate. Pyrimidines and piperazines are known to be the backbone of many bulk compounds and important core structures for approved drugs; studies have shown that combining a pyridine ring with a piperazine moiety within a single structural framework enhances biological activity.
Pyrimidines
Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.
Triazoles
Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.